These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35232628)

  • 1. Letter comments on anti-PD(L)1 immunotherapies in patients with cancer and with pre-existing systemic sclerosis: a post-marketed safety assessment study.
    Ikeda S; Yamaguchi Y; Baba T; Sekine A; Ogura T
    Eur J Cancer; 2022 Apr; 165():205-207. PubMed ID: 35232628
    [No Abstract]   [Full Text] [Related]  

  • 2. The letter responds to comment on: Anti-PD(L)1 immunotherapies in patients with cancer and with pre-existing systemic sclerosis: a post-marketed safety assessment study.
    Panhaleux M; Launay D; Penel N; Lambotte O; Forestier A
    Eur J Cancer; 2022 Apr; 165():208-209. PubMed ID: 35236567
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study.
    Panhaleux M; Espitia O; Terrier B; Manson G; Maria A; Humbert S; Godbert B; Perrin J; Achille A; Arrondeau J; Kostine M; Fallet V; Pugnet G; Chaigne B; Champiat S; Laparra A; Danlos FX; Launay D; Penel N; Lambotte O; Michot JM; Forestier A
    Eur J Cancer; 2022 Jan; 160():134-139. PubMed ID: 34810048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted immunotherapies in systemic sclerosis.
    Avouac J; Allanore Y
    Clin Exp Rheumatol; 2014; 32(2 Suppl 81):165-72. PubMed ID: 24742451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of ischemic colitis and scleroderma renal crisis following methylprednisolone pulse therapy for progressive systemic sclerosis.
    Yamanishi Y; Yamana S; Ishioka S; Yamakido M
    Intern Med; 1996 Jul; 35(7):583-6. PubMed ID: 8842768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of systemic sclerosis.
    Birk RE
    Mod Treat; 1966 Nov; 3(6):1287-301. PubMed ID: 4959071
    [No Abstract]   [Full Text] [Related]  

  • 7. D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma).
    Medsger TA
    Arthritis Rheum; 1987 Jul; 30(7):832-4. PubMed ID: 3304300
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic sclerosis and malignancy--are they related?
    Medsger TA
    J Rheumatol; 1985 Dec; 12(6):1041-3. PubMed ID: 3005560
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of intravenous methylprednisolone therapy in patients suffering from systemic sclerosis.
    Vanthuyne M; Depresseux G; Houssiau FA
    Scand J Rheumatol; 2010 Mar; 39(2):178-9. PubMed ID: 20038263
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic and localized scleroderma in children: current and future treatment options.
    Rosenkranz ME; Agle LM; Efthimiou P; Lehman TJ
    Paediatr Drugs; 2006; 8(2):85-97. PubMed ID: 16608370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current therapy of systemic sclerosis (scleroderma).
    Müller-Ladner U; Benning K; Lang B
    Clin Investig; 1993 Apr; 71(4):257-63. PubMed ID: 8471811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal Involvement in Systemic Sclerosis: An Update.
    Chrabaszcz M; Małyszko J; Sikora M; Alda-Malicka R; Stochmal A; Matuszkiewicz-Rowinska J; Rudnicka L
    Kidney Blood Press Res; 2020; 45(4):532-548. PubMed ID: 32521536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis in the course of systemic sclerosis.
    Chroni E; Paschalis C; Stergiou T; Vlahanastasi C; Andonopoulos AP
    Ann Rheum Dis; 2002 Feb; 61(2):188. PubMed ID: 11796418
    [No Abstract]   [Full Text] [Related]  

  • 14. Peristomal morphoea in a patient with systemic sclerosis.
    Jiang KW; Zagarella SS; Chan L; Harris A
    Australas J Dermatol; 2020 Nov; 61(4):e451-e452. PubMed ID: 32567671
    [No Abstract]   [Full Text] [Related]  

  • 15. Scleroderma renal crisis sine scleroderma in pregnancy: a case report.
    Gore JE; Brown AN
    Clin Exp Rheumatol; 2006; 24(1):87-8. PubMed ID: 16539825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Digital ulcers in systemic sclerosis].
    Guillevin L
    Presse Med; 2008 Apr; 37(4 Pt 2):735-6. PubMed ID: 18258409
    [No Abstract]   [Full Text] [Related]  

  • 17. Recommendations for the management and treatment of systemic sclerosis.
    Sampaio-Barros PD; Zimmermann AF; Müller Cde S; Borges CT; Freire EA; Maretti GB; Marques Neto JF; Salgado MC; Sauma Mde F; de Azevedo MN; Fontenelle S; Kayser C;
    Rev Bras Reumatol; 2013; 53(3):258-75. PubMed ID: 24051909
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressive systemic sclerosis.
    Mitra K
    J Indian Med Assoc; 1988 Feb; 86(2):52-3. PubMed ID: 3397565
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cancers in systemic sclerosis : risk factors, impact on survival and literature review].
    Catano J; Guedon A; Riviere S; Carrat F; Mahevas T; Fain O; Mekinian A
    Rev Med Interne; 2019 Oct; 40(10):637-644. PubMed ID: 31255252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic scleroderma (progressive systemic sclerosis), chemical diabetes mellitus, psoriasis.
    Sauter LS
    Arch Dermatol; 1971 Jun; 103(6):682-5. PubMed ID: 5555861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.